Table 5. Characteristics of the patients with VTE events.
*Mann-Whitney U test.
**Pearson chi-square.
***Fisher’s exact test.
IQR: interquartile range; BMI: body mass index; VTE: venous thromboembolic; DVT: deep venous thrombosis; PE: pulmonary embolism; S-RYGB: standard Roux-en-Y gastric bypass; M-RYGB: metabolic Roux-en-Y gastric bypass; SADI-S: single anastomosis duodeno-ileal bypass with sleeve gastrectomy; OSA: obstructive sleep apnea
| Variables | n = 4 (0.44%) | p-Value | |
| Age, years (IQR) | 57 (41.5-59.8) | 0.08* | |
| Female, n (%) | 3 (75%) | 0.974** | |
| Preoperative BMI, kg/m2 (IQR) | 42.5 (35-45) | 0.985* | |
| Postdischarge VTE events, n (%) | 3 (0.75%) | - | |
| Time after surgery, months (IQR) | 4 (2-9) | - | |
| Type of VTE event, n (%) | DVT | 2 (0.22%) | - |
| PE | 1 (0.11%) | ||
| DVT+PE | 1 (0.11%) | ||
| Procedure, n (%) | S-RYGB | 1 (0.11%) | - |
| M-RYGB | 2 (0.22%) | ||
| SADI-S | 1 (0.11%) | ||
| Patient’s risk factors, n (%) | Arterial hypertension | 3 (0.33%) | 0.162*** |
| Diabetes Mellitus | 2 (0.22%) | 0.157*** | |
| Hyperlipidemia | 2 (0.22%) | 0.585*** | |
| Smoking habits | 1 (0.11%) | 0.773*** | |
| OSA | 1 (0.11%) | 0.465*** | |
| Combined oral contraceptive use | 1 (0.11%) | 0.616*** | |
| Reintervention | 1 (0.11%) | 0.06** | |
| Mortality, n (%) | 0 (0%) | - | |